The frequency of TIMs among CD45+ cells in the tumor periphery was significantly higher than that recorded in the tumor center, accounting for nearly 30% of CD45+ cells in the periphery and 18% in the central part (Figure 1D). The gene discussed is PTPRC; the disease is neoplasm.